Mark Kagan
Impact in
- Chemical Health and Safety top 5%
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Metabolomics and Mass Spectrometry Studies 2
- Oncology 5
- HER2/EGFR in Cancer Research 2
- Co-authors
- Klaus D. Brunnemann (3 shared papers)Jonathan E. Cox (2 shared papers)Dietrich Hoffmann (3 shared papers)Stephen S. Hecht (3 shared papers)Steven G. Carmella (2 shared papers)Assieh A. Melikian (2 shared papers)Heyi Li (2 shared papers)Peter G. Foiles (1 shared paper)
- Journals
- Drug Metabolism and Disposition (3 papers)Blood (2 papers)Carcinogenesis (2 papers)International Journal of Cancer (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Mark Kagan
19 papers receiving 737 citations
Peers
Comparison fields: 5 of 108
- Chemical Health and Safety 16
- Cancer Research 309
- Health, Toxicology and Mutagenesis 218
- Pharmacology 69
- Spectroscopy 76
Countries citing papers authored by Mark Kagan
This map shows the geographic impact of Mark Kagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kagan more than expected).
Fields of papers citing papers by Mark Kagan
This network shows the impact of papers produced by Mark Kagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kagan. The network helps show where Mark Kagan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Kagan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 130 | |
| 2 | 1991 | 100 | |
| 3 | 2000 | 99 | |
| 4 | 1999 | 87 | |
| 5 | Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers. | 1990 | 81 |
| 6 | 2018 | 78 | |
| 7 | 2012 | 51 | |
| 8 | 1989 | 41 | |
| 9 | 1991 | 24 | |
| 10 | 2005 | 21 | |
| 11 | 2012 | 19 | |
| 12 | 2017 | 13 | |
| 13 | 1989 | 10 | |
| 14 | 2024 | 9 | |
| 15 | 2009 | 8 | |
| 16 | 2021 | 3 | |
| 17 | Quantification of 4-hydroxy-1-(3-pyridyl)-1-butanone released from human haemoglobin as a dosimeter for exposure to tobacco-specific nitrosamines. | 1991 | 2 |
| 18 | 2024 | 1 | |
| 19 | 2013 | 1 |
About Mark Kagan
Mark Kagan is a scholar working on Molecular Biology, Oncology, Spectroscopy, Health, Toxicology and Mutagenesis and Pharmacology, having authored 19 papers that have together received 778 indexed citations. Recurring topics across this work include Analytical Chemistry and Chromatography (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Advanced Chemical Sensor Technologies (2 papers), Smoking Behavior and Cessation (2 papers), HER2/EGFR in Cancer Research (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Toxic Organic Pollutants Impact (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). The work is most often cited by research in Chemical Health and Safety (16 citations), Cancer Research (309 citations), Health, Toxicology and Mutagenesis (218 citations), Pharmacology (69 citations) and Spectroscopy (76 citations). Mark Kagan has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Klaus D. Brunnemann, Jonathan E. Cox, Dietrich Hoffmann, Stephen S. Hecht, Steven G. Carmella, Assieh A. Melikian, Heyi Li, Peter G. Foiles, Gary D. Stoner and Shobha A. Akerkar. Their work appears in journals such as Drug Metabolism and Disposition, Blood, Carcinogenesis, International Journal of Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.